These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7727830)

  • 1. Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts.
    Kikuchi K; Kadono T; Fujimoto M; Ihn H; Sato S; Takehara K
    Dermatology; 1995; 190(2):104-8. PubMed ID: 7727830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.
    Kikuchi K; Ihn H; Sato S; Igarashi A; Soma Y; Ishibashi Y; Takehara K
    Arch Dermatol Res; 1994; 286(2):77-80. PubMed ID: 8154928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of various growth factors and histamine on cultured keloid fibroblasts.
    Kikuchi K; Kadono T; Takehara K
    Dermatology; 1995; 190(1):4-8. PubMed ID: 7894095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
    Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
    Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.
    Scheja A; Wildt M; Wollheim FA; Akesson A; Saxne T
    Rheumatology (Oxford); 2000 Oct; 39(10):1110-3. PubMed ID: 11035131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of heat-shock protein 47 is associated with overproduction of type I procollagen in systemic sclerosis skin fibroblasts.
    Kuroda K; Tsukifuji R; Shinkai H
    J Invest Dermatol; 1998 Dec; 111(6):1023-8. PubMed ID: 9856811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
    Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
    Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.
    McWhirter A; Colosetti P; Rubin K; Miyazono K; Black C
    Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis.
    Kawaguchi Y; Kitani A; Hara M; Harigai M; Hirose T; Suzuki K; Kawakami M; Hidaka T; Ishizuka T; Kawagoe M
    J Rheumatol; 1992 Aug; 19(8):1195-201. PubMed ID: 1328634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha and interferon-gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture.
    Kähäri VM; Heino J; Vuorio T; Vuorio E
    Biochim Biophys Acta; 1988 Jan; 968(1):45-50. PubMed ID: 3122841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen].
    Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R
    Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
    Nakashima J; Sumitomo M; Miyajima A; Jitsukawa S; Saito S; Tachibana M; Murai M
    J Urol; 1997 May; 157(5):1736-9. PubMed ID: 9112516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
    Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.